Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Calderon

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Frontiers in Pharmacology|September 12, 2022
Immune-related adverse events of biological immunotherapies used in COVID-19Daniela Baracaldo-Santamaría, Giovanna María Barros-Arias, Felipe Hernández-Guerrero, et al.
International Journal of Molecular Sciences|September 9, 2022
Thermodynamic Analysis of the Solubility of Isoniazid in (PEG 200 + Water) Cosolvent Mixtures from 278.15 K to 318.15 KDaniela Baracaldo-Santamaría, Carlos Alberto Calderon-Ospina, Claudia Patricia Ortiz, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?Daniela Baracaldo-Santamaría, Juan David Cala-Garcia, Germán José Medina-Rincón, et al.
Pharmacogenomics and Personalized Medicine|March 19, 2020
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug ReactionsCarlos Alberto Calderon-Ospina, Mario Hernández-Sómerson, Ana María García, et al.
Therapeutic Advances in Drug Safety|October 10, 2022
Definition of self-medication: a scoping reviewDaniela Baracaldo-Santamaría, Maria José Trujillo-Moreno, Andrés M Pérez-Acosta, et al.
Journal of Clinical Medicine|July 14, 2023
Making Sense of Composite Endpoints in Clinical ResearchDaniela Baracaldo-Santamaría, John Edwin Feliciano-Alfonso, Raul Ramirez-Grueso, et al.
Pharmaceutics|January 21, 2022
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to BedsideDaniela Baracaldo-Santamaría, Daniel Felipe Ariza-Salamanca, María Gabriela Corrales-Hernández, et al.
International Journal of Molecular Sciences|August 7, 2021
Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationDaniela Baracaldo-Santamaría, Kevin Llinás-Caballero, Julián Miguel Corso-Ramirez, et al.
Biomedicines|September 23, 2022
Connexins and Pannexins: Important Players in Neurodevelopment, Neurological Diseases, and Potential TherapeuticsDaniela Baracaldo-Santamaría, María Gabriela Corrales-Hernández, Maria Camila Ortiz-Vergara, et al.
Therapeutic Advances in Drug Safety|June 1, 2022
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional studyMaria Jose Nino-Orrego, Daniela Baracaldo-Santamaría, Claudia Patricia Ortiz, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|September 12, 2022
Immune-related adverse events of biological immunotherapies used in COVID-19Daniela Baracaldo-Santamaría, Giovanna María Barros-Arias, Felipe Hernández-Guerrero, et al.
International Journal of Molecular Sciences|September 9, 2022
Thermodynamic Analysis of the Solubility of Isoniazid in (PEG 200 + Water) Cosolvent Mixtures from 278.15 K to 318.15 KDaniela Baracaldo-Santamaría, Carlos Alberto Calderon-Ospina, Claudia Patricia Ortiz, et al.
Antibiotics (Basel, Switzerland)|May 28, 2022
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?Daniela Baracaldo-Santamaría, Juan David Cala-Garcia, Germán José Medina-Rincón, et al.
Pharmacogenomics and Personalized Medicine|March 19, 2020
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug ReactionsCarlos Alberto Calderon-Ospina, Mario Hernández-Sómerson, Ana María García, et al.
Therapeutic Advances in Drug Safety|October 10, 2022
Definition of self-medication: a scoping reviewDaniela Baracaldo-Santamaría, Maria José Trujillo-Moreno, Andrés M Pérez-Acosta, et al.
Journal of Clinical Medicine|July 14, 2023
Making Sense of Composite Endpoints in Clinical ResearchDaniela Baracaldo-Santamaría, John Edwin Feliciano-Alfonso, Raul Ramirez-Grueso, et al.
Pharmaceutics|January 21, 2022
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to BedsideDaniela Baracaldo-Santamaría, Daniel Felipe Ariza-Salamanca, María Gabriela Corrales-Hernández, et al.
International Journal of Molecular Sciences|August 7, 2021
Genetic and Molecular Aspects of Drug-Induced QT Interval ProlongationDaniela Baracaldo-Santamaría, Kevin Llinás-Caballero, Julián Miguel Corso-Ramirez, et al.
Biomedicines|September 23, 2022
Connexins and Pannexins: Important Players in Neurodevelopment, Neurological Diseases, and Potential TherapeuticsDaniela Baracaldo-Santamaría, María Gabriela Corrales-Hernández, Maria Camila Ortiz-Vergara, et al.
Therapeutic Advances in Drug Safety|June 1, 2022
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional studyMaria Jose Nino-Orrego, Daniela Baracaldo-Santamaría, Claudia Patricia Ortiz, et al.
Pageof 3